TWO SIGMA ADVISERS, LP - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$389,708
-90.5%
18,700
-89.0%
0.00%
-90.0%
Q2 2023$4,081,080
+1663.0%
170,400
+1285.4%
0.01%
+900.0%
Q1 2023$231,486
-1.1%
12,300
-25.9%
0.00%0.0%
Q2 2022$234,000
-83.0%
16,600
-70.8%
0.00%
-75.0%
Q1 2022$1,378,000
-71.8%
56,900
-70.0%
0.00%
-69.2%
Q1 2021$4,889,000
-78.4%
189,500
-55.2%
0.01%
-78.3%
Q4 2020$22,592,000
-14.2%
422,600
-33.8%
0.06%
-20.0%
Q3 2020$26,326,000
+35.8%
638,200
+59.5%
0.08%
+31.6%
Q2 2020$19,393,000
+643.9%
400,100
+548.5%
0.06%
+470.0%
Q1 2020$2,607,000
-41.8%
61,700
-41.1%
0.01%0.0%
Q4 2019$4,483,000
+16.1%
104,800
-2.3%
0.01%
+11.1%
Q3 2019$3,862,000
+102.6%
107,300
+50.5%
0.01%
+80.0%
Q2 2019$1,906,000
-2.9%
71,300
-2.5%
0.01%0.0%
Q1 2019$1,963,000
+122.8%
73,100
+34.1%
0.01%
+150.0%
Q4 2018$881,00054,5000.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders